Health - Tuberculosis – Shorter treatment times (May 17, 2016)

In 2015, a study known as “Initiative 5%” – funded by Expertise France in nine French-speaking African countries and coordinated by the International Union Against Tuberculosis and Lung Disease – demonstrated that it was possible to shorten the course of treatment for multidrug-resistant TB from 24 to nine months without major secondary effects.

As a result of this French-funded study, the World Health Organization is now recommending a shorter course of treatment for multidrug-resistant TB.

This will open the way to simpler and less expensive care – something that offers great hope in the fight against this disease.

There are three times more cases of multidrug-resistant TB now than in 2010. Detected in more than 100 countries, such cases now represent 5% of all tuberculosis cases, 14% of deaths, and 27% of costs.

France is the second-largest international contributor to the fight against tuberculosis, particularly through its support for the Global Fund to Fight AIDS, Tuberculosis, and Malaria and for UNITAID.